A Study of KC1086 in Patients With Advanced Solid Tumors

NCT07118709 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors Cancer

Interventions

DRUG: KC1086

Sponsor

Beijing Konruns Pharmaceutical Co., Ltd.